Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Sweden
/
Healthcare
Create a narrative
Getinge
OM:GETI B Community
1
Narratives
written by author
0
Comments
on narratives written by author
12
Fair Values set
on narratives written by author
Create a narrative
Getinge
Popular
Undervalued
Overvalued
Getinge
WA
Analyst Price Target
Consensus Narrative from 8 Analysts
Acquisition Of Paragonix Technologies Will Strengthen Organ Transportation Solutions
Key Takeaways Acquiring Paragonix and the phaseout of underperforming portfolios are set to enhance growth and profitability through market expansion and resource optimization. Strong order intake, productivity measures, and strategic integration aim to boost margins and sustain revenue growth in high-demand sectors.
View narrative
SEK 235.11
FV
6.5% undervalued
intrinsic discount
5.71%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
23 days ago
author updated this narrative
Your Valuation for
GETI B
Getinge
Your Fair Value
SEK
Current Price
SEK 219.80
3.0% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-967m
45b
2015
2018
2021
2024
2025
2027
2030
Revenue SEK 44.7b
Earnings SEK 2.1b
Advanced
Set as Fair Value